Page 61 - IMO-1-1

Innovative Medicines & Omics Antioxidant nanomedicines for therapies

nanoparticles targeting synovium for osteoarthritis 192. Rodan GA, Martin TJ. Therapeutic approaches to bone
therapy. Biomaterials. 2022;283:121437. diseases. Science. 2000;289(5484):1508-1514.
doi: 10.1016/j.biomaterials.2022.121437 doi: 10.1126/science.289.5484.1508
181. Zhou F, Mei J, Yang S, et al. Modified ZIF-8 nanoparticles 193. Reid IR, Billington EO. Drug therapy for osteoporosis in
attenuate osteoarthritis by reprogramming the metabolic older adults. Lancet. 2022;399(10329):1080-1092.
pathway of synovial macrophages. ACS Appl Mater doi: 10.1016/S0140-6736(21)02646-5
Interfaces. 2020;12(2):2009-2022.
194. Ye C, Zhang W, Zhao Y, et al. Prussian blue nanozyme
doi: 10.1021/acsami.9b16327 normalizes microenvironment to delay osteoporosis. Adv
182. Zhao C, Chen J, Ye J, et al. Structural transformative Healthc Mater. 2022;11(19):e2200787.
antioxidants for dual-responsive anti-inflammatory doi: 10.1002/adhm.202200787
delivery and photoacoustic inflammation imaging. Angew
Chem Int Ed Engl. 2021;60(26):14458-14466. 195. Tian Q, Wang W, Cao L, et al. Multifaceted catalytic ROS-
scavenging via electronic modulated metal oxides for
doi: 10.1002/anie.202100873 regulating stem cell fate. Adv Mater. 2022;34(43):e2207275.
183. Yang B, Yin J, Chen Y, et al. 2D-black-phosphorus-reinforced doi: 10.1002/adma.202207275
3D-printed scaffolds: A stepwise countermeasure for
osteosarcoma. Adv Mater. 2018;30(10):1705611. 196. Wu Z, Sun Y, Mu S, et al. Manganese-based antioxidase-
inspired biocatalysts with axial Mn-N5 Sites and 2D d-pi-
doi: 10.1002/adma.201705611 conjugated networks for rescuing stem cell fate. Angew
184. Lu H, Wei J, Liu K, et al. Radical-scavenging and Chem Int Ed Engl. 2023;62:e202302329.
subchondral bone-regenerating nanomedicine for doi: 10.1002/anie.202302329
osteoarthritis treatment. ACS Nano. 2023;17(6):6131-6146.
197. Terstappen GC, Meyer AH, Bell RD, Zhang W. Strategies
doi: 10.1021/acsnano.3c01789 for delivering therapeutics across the blood-brain barrier.
185. Kumar S, Adjei IM, Brown SB, Liseth O, Sharma B. Manganese Nat Rev Drug Discov. 2021;20(5):362-383.
dioxide nanoparticles protect cartilage from inflammation- doi: 10.1038/s41573-021-00139-y
induced oxidative stress. Biomaterials. 2019;224:119467.
198. Furtado D, Bjornmalm M, Ayton S, Bush AI, Kempe K,
doi: 10.1016/j.biomaterials.2019.119467 Caruso F. Overcoming the blood-brain barrier: The role
186. Klibanski A, Adams-Campbell L, Bassford T, et al. of nanomaterials in treating neurological diseases. Adv
Osteoporosis prevention, diagnosis, and therapy. JAMA. Mater. 2018;30(46):e1801362.
2001;285(6):785-795. doi: 10.1002/adma.201801362
187. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: Now 199. Tang W, Fan W, Lau J, Deng L, Shen Z, Chen X. Emerging
and the future. Lancet. 2011;377(9773):1276-1287. blood-brain-barrier-crossing nanotechnology for brain
doi: 10.1016/S0140-6736(10)62349-5 cancer theranostics. Chem Soc Rev. 2019;48(11):2967-3014.
188. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone doi: 10.1039/c8cs00805a
remodeling. Emerging insights into the pathophysiology of 200. Krol S, Macrez R, Docagne F, et al. Therapeutic benefits from
osteoporosis. N Engl J Med. 1995;332(5):305-311. nanoparticles: the potential significance of nanoscience in
doi: 10.1056/NEJM199502023320506 diseases with compromise to the blood brain barrier. Chem
Rev. 2013;113(3):1877-1903.
189. Bax BE, Alam AS, Banerji B, et al. Stimulation of osteoclastic
bone resorption by hydrogen peroxide. Biochem Biophys doi: 10.1021/cr200472g
Res Commun. 1992;183(3):1153-1158. 201. Butterfield DA, Halliwell B. Oxidative stress, dysfunctional
doi: 10.1016/s0006-291x(05)80311-0 glucose metabolism and Alzheimer disease. Nat Rev
Neurosci. 2019;20(3):148-160.
190. Agidigbi TS, Kim C. Reactive oxygen species in osteoclast
differentiation and possible pharmaceutical targets doi: 10.1038/s41583-019-0132-6
of ROS-mediated osteoclast diseases. Int J Mol Sci. 202. Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease.
2019;20(14):3576. Lancet. 2006;368(9533):387-403.
doi: 10.3390/ijms20143576 doi: 10.1016/S0140-6736(06)69113-7
191. Teitelbaum SL. Bone resorption by osteoclasts. Science. 203. Tonnies E, Trushina E. Oxidative stress, synaptic dysfunction, and
2000;289(5484):1504-1508. Alzheimer’s disease. J Alzheimers Dis. 2017;57(4):1105-1121.
doi: 10.1126/science.289.5484.1504 doi: 10.3233/JAD-161088

Volume 1 Issue 1 (2024) 55 doi: 10.36922/imo.2527